GlassScriptPhysician profile
Steven Scott Goldberg
NPI 1447202049
$131,473.40
in general payments reported to CMS, 2019-2025
9 companies · $122K in 2025
The $122K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,660 · 2020: $225 · 2021: $203 · 2022: $1,483 · 2023: $2,228 · 2024: $1,852 · 2025: $122K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $113K · Travel and Lodging: $9,856 · Food and Beverage: $2,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $113,411.05 |
| Travel and Lodging | $9,856.32 |
| Food and Beverage | $2,635.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $130,409.57 | 2019-2025 | R1 Reverse Total Shoulder, Csr & R1 Reverse Total Shoulder Systems, Archer 3d Software |
| Zimmer Biomet Holdings, INC. | $579.49 | 2019-2024 | Comprehensive, Trabecular Metal, Comprehensive Shoulder System |
| Stryker Corporation | $226.26 | 2025 | Pangea |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Arthrex, INC. | $51.13 | 2023 | Arthrex |
| Smith+Nephew, INC. | $34.59 | 2019 | |
| Heraeus Medical, LLC. | $34.17 | 2021 | |
| Abbott Laboratories | $22.04 | 2021 | |
| Nevro Corp. | $15.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$47,039,247.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.